Product Information
RELPAX 40 MG TABLET is a brand product labeled by Roerig, priced at $77.1444 per EA under NDC 00049234005. Its NADAC has been published 652 times since Nov 28, 2013.
FDA first approved this application on Dec 26, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
RoerigNDC
00049234005
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
ELETRIPTAN HYDROBROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA021016FDA Approved
12/26/2002
TE Code
AB
On Market Since
12/26/2002
Pharmacological Classes
Price Statistics
The NADAC for RELPAX 40 MG TABLET has been published 652 times since Nov 28, 2013, and over the history we have for it it has risen 153.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $77.1444 per EA |
|---|---|
| All-time high | $77.6851 (May 15, 2024) |
| All-time low | $30.3842 (Nov 28, 2013) |
| 52-week high | $77.5226 |
| 52-week low | $77.1444 |
| Median price | $62.5681 |
| Average price | $59.3712 |
| Largest weekly change | +12.0% (Jun 8, 2016) |
| Weeks tracked | 652 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
-0.0%
1Y
-0.5%
3Y
+4.3%
5Y
+17.5%
All
+153.9%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RELPAX 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RELPAX 40 MG TABLET, manufactured by Roerig, is $77.1444 per EA (NDC 00049234005), effective May 20, 2026.
How has the price of RELPAX 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for RELPAX 40 MG TABLET has risen 153.9%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RELPAX 40 MG TABLET?
Since Nov 28, 2013, the NADAC for RELPAX 40 MG TABLET has ranged from a low of $30.3842 (Nov 28, 2013) to a high of $77.6851 (May 15, 2024), with a median of $62.5681 per EA.
Are there cheaper alternatives to RELPAX 40 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ELETRIPTAN HBR 40 MG TABLET, is $1.9092 per EA — about 98% below RELPAX 40 MG TABLET.
Who manufactures RELPAX 40 MG TABLET?
RELPAX 40 MG TABLET (NDC 00049234005) is labeled by Roerig, and CMS classifies it as a brand product.